Picture of Abbvie logo

ABBV Abbvie Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Momentum

Relative Strength (%)
1m+8.85%
3m+19.97%
6m+11.42%
1yr+60.43%
Volume Change (%)
10d/3m-5.82%
Price vs... (%)
52w High-6.93%
50d MA+9.88%
200d MA+9.68%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)13.92
PEG Ratio (f)n/a
EPS Growth (f)-12.46%
Dividend Yield (f)3.62%
Valuation (ttm)IndustryMarket
Price to Book Value18.1
Price to Tang. Bookn/a
Price to Free Cashflow13.21
Price to Sales5.01
EV to EBITDA13.37

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital16.29%
Return on Equity90.32%
Operating Margin30.59%

Financial Summary

Year End 31st DecUnit201720182019202020212022E2023ECAGR / Avg
Total Revenue$m28,21632,75333,26645,80456,19758,332.7454,089.7616.99%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+4.54+59.17-8.27-36.44+99.99+89.51-16.25n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Abbvie EPS forecast chart

Profile Summary

AbbVie Inc. is a research-based biopharmaceutical company, which is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. It offers products in various therapeutic categories, including immunology products, which include Humira, Skyrizi and Rinvoq; oncology products, which include Imbruvica and Venclexta; aesthetics products that include Botox Cosmetic, Juvederm Collection and others; neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; eye care products consists of Lumigan, Alphagan and Restasis; women's health products include Lo Loestrin, Orilissa and others; and other products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. Its products are sold to wholesalers, government agencies, health care facilities and independent retailers. It also discovers and develop antibody medicines that target difficult-to-drug disease-causing proteins, such as G protein-coupled receptors (GPCRs).

Directors

Last Annual
December 31st, 2021
Last Interim
September 30th, 2022
Incorporated
April 10th, 2012
Public Since
January 2nd, 2013
No. of Shareholders
46,139
No. of Employees
50,000
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
us flag iconNew York Stock Exchange
Shares in Issue
1,768,480,508

ABBV Share Price Performance

Upcoming Events for ABBV

Dividend For ABBV.NLB - 0.2185 CAD

Dividend For ABBV.BA - 0.1480 USD

Dividend For ABBV34.SA - 0.4944 BRL

Dividend For ABBV.N - 1.4800 USD

Q4 2022 Abbvie Inc Earnings Release

Q1 2023 Abbvie Inc Earnings Release

AbbVie Inc Annual Shareholders Meeting

Similar to ABBV

Picture of Amneal Pharmaceuticals logo

Amneal Pharmaceuticals

us flag iconNew York Stock Exchange

Picture of Bausch Health Companies logo

Bausch Health Companies

us flag iconNew York Stock Exchange

Picture of Biohaven logo

Biohaven

us flag iconNew York Stock Exchange

Picture of Bristol-Myers Squibb Co logo

Bristol-Myers Squibb Co

us flag iconNew York Stock Exchange

Picture of Bristol-Myers Squibb Co logo

Bristol-Myers Squibb Co

us flag iconNew York Stock Exchange

FAQ

Or unlock with your email

Or unlock with your email